(2-trans,6-trans)-farnesol;
(E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol;
Stirrup-TPW;
Stirrup-HB;
(2E,6E)-3,7,11-Trimethyl-dodeca-2,6,10-trien-1-ol;
trans,trans-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol;
(2E,6E)-Farnesol;
all-trans-farnesol;
all-E-Farnesol;
Farnesoi;
farnesyl bromide;
2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, (E,E)-;
1,4-Cyclohexanediol;
(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol;
trans,trans-Farnesol;
2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, (2E,6E)-;
3,7,10-trimethyl-2,6,10-dodecatrien-1-ol;
ALL TRANS FARNESOL;
FARNESOLP;
trans-Farnesol;
Cyclohexan-1,4-diol;
Farnesol,(E,E);
3,7,11-Trimethyl-2,6,10-dodecatrienol;
(E)-farnesol;
farnesyl alcohol;
(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol;
3,7,11-Trimethyl-2,6,10-Dodecatrien-1-ol;
E,E-farnesol;
trans-1,4-cyclohexanediol;
Stirrup-CRW;
Polyprenol;
Stirrup-H;
Farnesol;
(E,E)-Farnesol;
3,7,11-Trimethyldodeca-2,6,10-trien-1-ol;
3,7,11-Trimethyldodeca-2-trans,6-trans,10-trien-1-ol;
Cyclohexane-1,4-diol;
fci119a;
Inhibitor A2;